2022
DOI: 10.1002/cnr2.1740
|View full text |Cite
|
Sign up to set email alerts
|

Screening for obstructive sleep apnoea in post‐treatment cancer patients

Abstract: Background and aims: For cancer patients, comorbid obstructive sleep apnea (OSA) poses additional risk to their surgical/anaesthetic outcomes, quality of life, and survival. However, OSA screening is not well-established in oncology settings. We tested two screening tools (STOP-Bang questionnaire [SBQ] and the at-home monitoring device, ApneaLink™Air), for predicting polysomnography (PSG) confirmed OSA in post-treatment cancer patients.Methods: Breast (n = 56), endometrial (n = 37) and melanoma patients (n … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2022
2022
2024
2024

Publication Types

Select...
4

Relationship

0
4

Authors

Journals

citations
Cited by 4 publications
references
References 77 publications
0
0
0
Order By: Relevance